Can Fite Biopharma Ltd ADR (CANF) — Cash Flow-to-Debt Ratio
Can Fite Biopharma Ltd ADR (CANF) has a Cash Flow-to-Debt Ratio of -0.67x as of June 2025, meaning its operating cash flow of $-2.38 Million could theoretically repay -1% of its total liabilities ($3.54 Million) in one year. See Can Fite Biopharma Ltd ADR (CANF) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Can Fite Biopharma Ltd ADR Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Can Fite Biopharma Ltd ADR across 15 annual periods. Also explore net asset growth rate of Can Fite Biopharma Ltd ADR to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Can Fite Biopharma Ltd ADR (2011–2025)
Year-by-year debt coverage analysis for Can Fite Biopharma Ltd ADR. For market capitalisation and broader financial context, see market cap of Can Fite Biopharma Ltd ADR.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.30x | $-9.02 Million | $3.92 Million | ▼ -10.9% |
| 2024 | -2.07x | $-7.64 Million | $3.68 Million | ▲ +8.0% |
| 2023 | -2.25x | $-8.44 Million | $3.75 Million | ▼ -0.4% |
| 2022 | -2.25x | $-10.80 Million | $4.81 Million | ▼ -33.7% |
| 2021 | -1.68x | $-9.86 Million | $5.87 Million | ▲ +52.0% |
| 2020 | -3.50x | $-12.06 Million | $3.45 Million | ▼ -85.0% |
| 2019 | -1.89x | $-10.83 Million | $5.73 Million | ▼ -124.6% |
| 2018 | -0.84x | $-4.16 Million | $4.94 Million | ▲ +57.8% |
| 2017 | -1.99x | $-9.52 Million | $4.78 Million | ▼ -40.5% |
| 2016 | -1.42x | $-8.93 Million | $6.29 Million | ▼ -118.2% |
| 2015 | -0.65x | $-4.65 Million | $7.16 Million | ▲ +70.5% |
| 2014 | -2.20x | $-7.33 Million | $3.33 Million | ▲ +44.5% |
| 2013 | -3.97x | $-8.63 Million | $2.18 Million | ▼ -113.7% |
| 2012 | -1.86x | $-4.35 Million | $2.34 Million | ▲ +45.6% |
| 2011 | -3.41x | $-5.50 Million | $1.61 Million | — |